Publication | Closed Access

Pharmacological profile of a novel phosphodiesterase 7A and -4 dual inhibitor, YM-393059, on acute and chronic inflammation models

InflammationAnti-inflammatoryAutoimmune DiseaseMedicineImmunologyChronic InflammationInflammatory MarkerPharmacological AgentAutoimmunityPharmacotherapyChronic Inflammation ModelsNovel Phosphodiesterase 7APharmacological ProfilePharmacologyInflammatory DiseaseDrug Discovery